This page provides a source hub for the medical information presented throughout the website.
Regulatory and prescribing sources
DailyMed — Abiraterone Acetate Tablets
Current U.S. labeling provides indications, dosing, administration, warnings, adverse reactions, drug interactions and pharmacology.
FDA — Zytiga Prescribing Information
FDA labeling provides authoritative U.S. information for the reference product.
European Medicines Agency — Zytiga EPAR
The EMA provides European authorization information and product documentation for Zytiga.
Generic-product references
EMA information for Abiraterone Accord and Abiraterone Mylan illustrates the regulatory distinction between a reference medicine and authorized generic products.
Clinical literature
The clinical development of abiraterone has been described in peer-reviewed literature, including studies of metastatic castration-resistant prostate cancer and the development history of the medicine.
Lenvaxen/website-specific product documentation
The identity, manufacturer and authorization status of the particular Abiraterone 250 mg product represented by this website require product-specific verification.